NeuroMetrix NURO
announced that it had entered into an agreement with Omron Medical
Devices, a subsidiary of Omron Healthcare China, to be the exclusive
distributor for NC-stat® DPNCheck® in China.
Earlier this year NeuroMetrix and Omron Healthcare Co. Ltd. announced a
partnership for the exclusive distribution of NC-stat DPNCheck in Japan.
NC-stat DPNCheck is a rapid, accurate and quantitative point-of-care
test for early detection of diabetic peripheral neuropathy (DPN), which
affects over half of people with diabetes. DPN causes significant
morbidity including pain, increased risk of falling in the elderly, and
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in